These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32041503)

  • 1. Severe hydralazine-induced lupus presenting as systemic lupus erythematosus.
    Rubin RL; Haluptzok RF; Davila LM
    Lupus; 2020 Apr; 29(5):509-513. PubMed ID: 32041503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydralazine-induced systemic lupus erythematosus presenting as pyoderma gangrenosum-like ulcers.
    Peterson LL
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):379-84. PubMed ID: 6231317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sweet syndrome associated with hydralazine-induced lupus erythematosus.
    Cartee TV; Chen SC
    Cutis; 2012 Mar; 89(3):121-4. PubMed ID: 22530328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocytotoxic antibodies in hydralazine-induced lupus erythematosus.
    Ryan PF; Hughes GR; Bernstein R; Mansilla R; Dollery CT
    Lancet; 1979 Dec; 2(8154):1248-9. PubMed ID: 92663
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydralazine antinuclear antibodies and the lupus syndrome.
    Ramsay LE; Silas J; Freestone S
    Br Med J (Clin Res Ed); 1982 Jun; 284(6330):1711. PubMed ID: 6805676
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydralazine, antinuclear antibodies, and the lupus syndrome.
    Mansilla-Tinoco R; Harland SJ; Ryan PJ; Bernstein RM; Dollery CT; Hughes GR; Bulpitt CJ; Morgan A; Jones JM
    Br Med J (Clin Res Ed); 1982 Mar; 284(6320):936-9. PubMed ID: 6802356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of immune response to hydralazine and development of antideoxyribonucleoprotein in patients receiving hydralazine.
    Carpenter JR; McDuffie FC; Sheps SG; Spiekerman RE; Brumfield H; King R
    Am J Med; 1980 Sep; 69(3):395-400. PubMed ID: 6968159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype.
    Russell GI; Bing RF; Jones JA; Thurston H; Swales JD
    Q J Med; 1987 Oct; 65(246):845-52. PubMed ID: 3329739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydralazine-induced lupus: maintaining vigilance with increased use in patients with heart failure.
    Finks SW; Finks AL; Self TH
    South Med J; 2006 Jan; 99(1):18-22. PubMed ID: 16466117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus.
    Nässberger L; Sjöholm AG; Jonsson H; Sturfelt G; Akesson A
    Clin Exp Immunol; 1990 Sep; 81(3):380-3. PubMed ID: 2168822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cadralazine challenge in patients with previous hydralazine-induced lupus: a 6-month study.
    Pålsson L; Weiner L; Englund G; Henning M
    Clin Pharmacol Ther; 1989 Aug; 46(2):177-81. PubMed ID: 2758727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to hydralazine and nuclear antigens in hydralazine-induced lupus erythematosus.
    Hahn BH; Sharp GC; Irvin WS; Kantor OS; Gardner CA; Bagby MK; Perry HM; Osterland CK
    Ann Intern Med; 1972 Mar; 76(3):365-74. PubMed ID: 4536922
    [No Abstract]   [Full Text] [Related]  

  • 14. Antinuclear antibodies following hydralazine toxicity.
    Condemi JJ; Moore-Jones D; Vaughan JH; Perry HM
    N Engl J Med; 1967 Mar; 276(9):486-91. PubMed ID: 4959828
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydralazine-induced lupus erythematosus-like syndrome.
    Irias JJ
    Am J Dis Child; 1975 Jul; 129(7):862-4. PubMed ID: 50009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypotensive agents, beta-blockers, and drug-induced lupus.
    Hughes GR
    Br Med J (Clin Res Ed); 1982 May; 284(6326):1358-9. PubMed ID: 6122487
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug-induced lupus erythematosus].
    Atzeni F; Marrazza MG; Sarzi-Puttini P; Carrabba M
    Reumatismo; 2003; 55(3):147-54. PubMed ID: 14513113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Procainamide- and hydralazine-induced antinuclear antibodies in Japanese].
    Nishikai M; Sugimoto M; Sato A; Honda M; Naito M; Nagoshi H
    Nihon Naika Gakkai Zasshi; 1987 May; 76(5):686-8. PubMed ID: 3509914
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute immunologic hydralazine reaction. Clinical and serological changes after hydralazine administration to a patient with circulating antinuclear antibodies.
    Alarcón-Segovia D
    Rev Invest Clin; 1972; 24(2):167-74. PubMed ID: 4538312
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydralazine and lupus nephritis.
    Ihle BU; Whitworth JA; Dowling JP; Kincaid-Smith P
    Clin Nephrol; 1984 Nov; 22(5):230-8. PubMed ID: 6240359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.